Psoriasis is a chronic inflammatory skin disease that affects millions of people worldwide.
There is still no effective approach for the clinical treatment of psoriasis. This is largely due to …

Purpose Psoriasis is a chronic, multi-system skin disease that can be influenced by
immunological, environmental, and genetic factors. Plasma metabolomic analysis can …

Psoriasis is a chronic inflammatory skin disease with significant physical and psychological
burdens. The interplay between the innate and adaptive immune systems is thought to …

Summary Background Psoriasis (Pso) is a chronic inflammatory skin disease that poses
both physical and psychological challenges. Dysbiosis of the skin microbiome has been …

Background Increasing evidence has shown that alterations in the intestinal microbiota play
an important role in the pathogenesis of psoriasis. The existing relevant studies focus on …

The skin microbiome is made of various microorganisms, most of which have the function of
protecting individuals from harmful pathogens, and they are involved in innate and adaptive …

Psoriasis affects the health of myriad populations around the world. The pathogenesis is
multifactorial, and the exact driving factor remains unclear. This condition arises from the …

Metabolic status and gut microecology are implicated in psoriasis. Methotrexate (MTX) is
usually the first-line treatment for this disease. However, the relationship between MTX and …

Background Psoriasis is an inflammatory skin disease associated with multiple
comorbidities and substantially diminishes patients' quality of life. The gut microbiome has …

Psoriasis is a chronic, inflammatory skin disease that affects 2‒3% of the global population.
Besides skin manifestations, patients with psoriasis have increased susceptibility to a …